Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

2.

Excellence in the treatment of patients with pituitary tumors.

Molitch ME, Findling JW, Clemmons DR.

Pituitary. 2018 Feb;21(1):107. doi: 10.1007/s11102-017-0848-0. No abstract available.

PMID:
29124563
3.

A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.

Wang TS, Kline G, Yen TW, Yin Z, Liu Y, Rilling W, So B, Findling JW, Evans DB, Pasieka JL.

World J Surg. 2018 Feb;42(2):466-472. doi: 10.1007/s00268-017-4327-6.

PMID:
29124355
4.

Diagnosis and Differential Diagnosis of Cushing's Syndrome.

Findling JW, Nieman L, Tabarin A.

N Engl J Med. 2017 Jul 13;377(2):e3. doi: 10.1056/NEJMc1705984. No abstract available.

PMID:
28704025
6.

Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.

Findling JW, Fleseriu M, Newell-Price J, Petersenn S, Pivonello R, Kandra A, Pedroncelli AM, Biller BM.

Endocrine. 2016 Nov;54(2):516-523. Epub 2016 May 21.

7.

Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome.

Poonuru S, Findling JW, Shaker JL.

Osteoporos Int. 2016 Dec;27(12):3645-3649. Epub 2016 Aug 15.

PMID:
27525744
8.

POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.

Carroll TB, Javorsky BR, Findling JW.

Endocr Pract. 2016 Oct;22(10):1216-1223. Epub 2016 Jul 13.

PMID:
27409817
9.

Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.

Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS.

Surgery. 2016 Jul;160(1):249-250. doi: 10.1016/j.surg.2016.04.012. Epub 2016 May 12. No abstract available.

PMID:
27181385
10.

Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.

Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS.

Surgery. 2016 Jan;159(1):259-65. doi: 10.1016/j.surg.2015.05.034. Epub 2015 Sep 28.

PMID:
26422766
11.

Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society.

J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29.

12.

Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients.

Javorsky BR, Carroll TB, Tritos NA, Salvatori R, Heaney AP, Fleseriu M, Biller BM, Findling JW.

Obes Surg. 2015 Dec;25(12):2306-13. doi: 10.1007/s11695-015-1681-z.

PMID:
25917980
13.

Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how?

Raff H, Auchus RJ, Findling JW, Nieman LK.

J Clin Endocrinol Metab. 2015 Feb;100(2):395-7. doi: 10.1210/jc.2014-3766. Epub 2014 Nov 25. No abstract available.

14.

Evolution, global warming, smart phones, and late-night salivary cortisol.

Findling JW.

Endocr Pract. 2015 Feb;21(2):205-7. doi: 10.4158/EP14451.CO. No abstract available.

PMID:
25370332
15.

Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone.

Fleseriu M, Findling JW, Koch CA, Schlaffer SM, Buchfelder M, Gross C.

J Clin Endocrinol Metab. 2014 Oct;99(10):3718-27. doi: 10.1210/jc.2014-1843. Epub 2014 Jul 11.

16.

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.

Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM; Pasireotide B2305 Study Group.

Clin Endocrinol (Oxf). 2014 Sep;81(3):408-17. doi: 10.1111/cen.12431. Epub 2014 Mar 27.

PMID:
24533697
17.

Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency.

Cornell RF, Kelly DF, Bordo G, Carroll TB, Duong HT, Kim J, Takasumi Y, Thomas JP, Wong YL, Findling JW.

Case Rep Endocrinol. 2013;2013:675298. doi: 10.1155/2013/675298. Epub 2013 Dec 22.

18.
19.

High variability in baseline urinary free cortisol values in patients with Cushing's disease.

Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Sen K, Salgado LR, Colao A, Biller BM; Pasireotide B2305 Study Group.

Clin Endocrinol (Oxf). 2014 Feb;80(2):261-9. doi: 10.1111/cen.12259. Epub 2013 Jul 15.

20.

The use of mifepristone in the treatment of Cushing's syndrome.

Carroll T, Findling JW.

Drugs Today (Barc). 2012 Aug;48(8):509-18. doi: 10.1358/dot.2012.48.8.1841299.

PMID:
22916338

Supplemental Content

Loading ...
Support Center